NANHUA FUTURES (02691) repurchased 308,500 shares on September 16 for approximately HK$2.0794 million.
NANHUA FUTURES (02691) announced that on September 16, 2026, it repurchased 308,500 shares for approximately HK$2.0794 million.
NANHUA FUTURES (02691) announced that on September 16, 2026, it repurchased 308,500 shares for approximately HK$2.0794 million.
Related Articles
ZYLOXTB (02190) repurchased 55,000 shares for approximately HK$1.1414 million on September 16.
FS.COM (03355) repurchased 254,200 shares for HK$10.4599 million on September 16.
CSPC PHARMA(01093): The Phase II clinical trial of SYH2069 injection for the treatment of adults with type 2 diabetes has officially been initiated at the first research center in China.
ZYLOXTB (02190) repurchased 55,000 shares for approximately HK$1.1414 million on September 16.
FS.COM (03355) repurchased 254,200 shares for HK$10.4599 million on September 16.
CSPC PHARMA(01093): The Phase II clinical trial of SYH2069 injection for the treatment of adults with type 2 diabetes has officially been initiated at the first research center in China.
RECOMMEND
